000			01489 a2200421 4500
005			20250512001000.0
264		0	_c19860313
008			198603s 0 0 eng d
022			_a0006-3223
024	7		_a10.1016/0006-3223(86)90009-0 _2doi
040			_aNLM _beng _cNLM
100	1		_aRiddle, M A
245	0	0	_aCerebrospinal fluid monoamine precursor and metabolite levels in children treated for leukemia: age and sex effects and individual variability. _h[electronic resource]
260			_bBiological psychiatry _cJan 1986
300			_a69-83 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdolescent
650	0	4	_aAge Factors
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aFemale
650	0	4	_aHomovanillic Acid _xcerebrospinal fluid
650	0	4	_aHumans
650	0	4	_aHydroxyindoleacetic Acid _xcerebrospinal fluid
650	0	4	_aInfant
650	0	4	_aLeukemia, Lymphoid _xcerebrospinal fluid
650	0	4	_aMale
650	0	4	_aSex Factors
650	0	4	_aTryptophan _xcerebrospinal fluid
650	0	4	_aTyrosine _xcerebrospinal fluid
700	1		_aAnderson, G M
700	1		_aMcIntosh, S
700	1		_aHarcherik, D F
700	1		_aShaywitz, B A
700	1		_aCohen, D J
773	0		_tBiological psychiatry _gvol. 21 _gno. 1 _gp. 69-83
856	4	0	_uhttps://doi.org/10.1016/0006-3223(86)90009-0 _zAvailable from publisher's website
999			_c2423688 _d2423688